Dr. Cyriac Abby Philips, a hepatologist based in Kerala, India, is currently embroiled in an intense national debate after years of using social media to challenge the scientific validity of alternative medical treatments. Frequently referred to as ‘The Liver Doc’, Dr. Philips has utilised his online platforms to debunk claims regarding various healthcare products, leading to a series of legal challenges and significant social media backlash.
Legal Challenges And Online Controversy
The conflict escalated in 2023 when a Kerala court ordered Dr. Philips to deactivate his X (formerly Twitter) account following a lawsuit filed by an manufacturer of Ayurvedic drugs. The doctor has faced persistent pressure, including mass reporting campaigns that have previously led to the suspension of his social media presence.
I am not against any system of medicine. I am against the lack of evidence and the promotion of unscientific claims that can harm patients.
Speaking on the nature of his activism, Dr. Philips has maintained that his primary concern is patient safety rather than an ideological opposition to traditional systems. Conversely, representatives of the alternative medicine industry have characterised his methods as disruptive, with one spokesperson stating that his approach is a threat to their culture and traditional healing practices.
Context Of The Science Versus Tradition Debate
The standoff highlights a deep-seated tension in India between modern, evidence-based medicine and government-supported traditional systems such as Ayurveda. Proponents of Ayurveda view it as a pillar of Indian cultural identity, while critics highlight the lack of rigorous clinical trial data for many commonly marketed products.
The debate is further complicated by the significant political backing of the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy (AYUSH). With financial interests within the alternative medicine sector growing rapidly, health experts remain divided on how to balance traditional integration with standardised medical safety protocols. As legal proceedings continue into 2024, the outcome of these cases is expected to set a significant precedent for how medical professionals in India navigate social media activism against powerful industry interests.